|
|
| | Mutant EGFR inhibitor Basic information |
| Product Name: | Mutant EGFR inhibitor | | Synonyms: | Mutant EGFR inhibitor;N-[5-[[5-Chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-2-propenamide;MDK3627;2-Propenamide, N-[5-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-;ABM-3627;ErbB-1,HER1,inhibit,EGFR,Inhibitor,Mutant EGFR inhibitor,Epidermal growth factor receptor | | CAS: | 1421373-62-7 | | MF: | C27H30ClN7O2 | | MW: | 520.03 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 1421373-62-7.mol |  |
| | Mutant EGFR inhibitor Chemical Properties |
| density | 1.316±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Powder | | pka | 12.66±0.70(Predicted) | | color | Light yellow to yellow |
| | Mutant EGFR inhibitor Usage And Synthesis |
| | Mutant EGFR inhibitor Preparation Products And Raw materials |
|